Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Mark P. Labrecque"'
Autor:
Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, Holly M Nguyen, Daniel W Lin, Eva Corey, Peter S Nelson, Colm Morrissey
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245602 (2021)
With the advent of potent second-line anti-androgen therapy, we and others have observed an increased incidence of androgen receptor (AR)-null small cell or neuroendocrine prostate cancer (SCNPC) in metastatic castration-resistant prostate cancer (mC
Externí odkaz:
https://doaj.org/article/17f5658b831148babc8033419b56fc67
Autor:
Joshi J. Alumkal, Zheng Xia, Joel A. Yates, Eric Campeau, Sanjay Lakhotia, Sarah Attwell, Emily M. Gesner, Arvind Rao, Armand Bankhead, Daniel E. Spratt, Eric J. Small, Felix Y. Feng, Wassim Abida, Rahul Aggarwal, Jonathan Z. Sexton, Samuel K. Handelman, Eva Corey, Peter S. Nelson, Ilsa M. Coleman, Jared M. Lucas, Colm Morrissey, Mark P. Labrecque, Himisha Beltran, Chao Zhang, Jacob A. Schwartzman, Joshua A. Urrutia, Eva S. Rodansky, Anbarasu Kumaraswamy, Xiangnan Guan, David Sampson, Daniel J. Coleman, Chelsea Jenkins, Katherine Welker Leng, William K. Storck, Duanchen Sun, Dae-Hwan Kim
Supplementary Figure S3 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::380d5df6f1565ca06f349c5d1c89338e
https://doi.org/10.1158/1078-0432.22481663.v1
https://doi.org/10.1158/1078-0432.22481663.v1
Autor:
Colm Morrissey, Peter S. Nelson, Eva Corey, Joshi J. Alumkal, Hung-Ming Lam, Daniel W. Lin, Lawrence D. True, David S. Rickman, Michael C. Haffner, Brian Hanratty, Dapei Li, Holly M. Nguyen, John K. Lee, Nicholas J. Brady, Bryce Lakely, Ilsa M. Coleman, Lisha G. Brown, Mark P. Labrecque
Neuroendocrine (NE) differentiation in metastatic castration-resistant prostate cancer (mCRPC) is an increasingly common clinical feature arising from cellular plasticity. We recently characterized two mCRPC phenotypes with NE features: androgen rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7251fe8abb50837833a891f60ad48364
https://doi.org/10.1158/0008-5472.c.6513135.v1
https://doi.org/10.1158/0008-5472.c.6513135.v1
Autor:
Colm Morrissey, Peter S. Nelson, Eva Corey, Joshi J. Alumkal, Hung-Ming Lam, Daniel W. Lin, Lawrence D. True, David S. Rickman, Michael C. Haffner, Brian Hanratty, Dapei Li, Holly M. Nguyen, John K. Lee, Nicholas J. Brady, Bryce Lakely, Ilsa M. Coleman, Lisha G. Brown, Mark P. Labrecque
All supplementary tables. Tables S1-S12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe7e61ef3a6a9121a2c6d4b6cf48f94
https://doi.org/10.1158/0008-5472.22428774
https://doi.org/10.1158/0008-5472.22428774
Autor:
Joshi J. Alumkal, Zheng Xia, Joel A. Yates, Eric Campeau, Sanjay Lakhotia, Sarah Attwell, Emily M. Gesner, Arvind Rao, Armand Bankhead, Daniel E. Spratt, Eric J. Small, Felix Y. Feng, Wassim Abida, Rahul Aggarwal, Jonathan Z. Sexton, Samuel K. Handelman, Eva Corey, Peter S. Nelson, Ilsa M. Coleman, Jared M. Lucas, Colm Morrissey, Mark P. Labrecque, Himisha Beltran, Chao Zhang, Jacob A. Schwartzman, Joshua A. Urrutia, Eva S. Rodansky, Anbarasu Kumaraswamy, Xiangnan Guan, David Sampson, Daniel J. Coleman, Chelsea Jenkins, Katherine Welker Leng, William K. Storck, Duanchen Sun, Dae-Hwan Kim
Supplementary Data from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212ea32b543bc433b2e2d94d66815153
https://doi.org/10.1158/1078-0432.22481681
https://doi.org/10.1158/1078-0432.22481681
Autor:
Colm Morrissey, Peter S. Nelson, Eva Corey, Joshi J. Alumkal, Hung-Ming Lam, Daniel W. Lin, Lawrence D. True, David S. Rickman, Michael C. Haffner, Brian Hanratty, Dapei Li, Holly M. Nguyen, John K. Lee, Nicholas J. Brady, Bryce Lakely, Ilsa M. Coleman, Lisha G. Brown, Mark P. Labrecque
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf989e8a48b3726f7dd840afd96b4b97
https://doi.org/10.1158/0008-5472.22428777
https://doi.org/10.1158/0008-5472.22428777
Autor:
Joshi J. Alumkal, Zheng Xia, Joel A. Yates, Eric Campeau, Sanjay Lakhotia, Sarah Attwell, Emily M. Gesner, Arvind Rao, Armand Bankhead, Daniel E. Spratt, Eric J. Small, Felix Y. Feng, Wassim Abida, Rahul Aggarwal, Jonathan Z. Sexton, Samuel K. Handelman, Eva Corey, Peter S. Nelson, Ilsa M. Coleman, Jared M. Lucas, Colm Morrissey, Mark P. Labrecque, Himisha Beltran, Chao Zhang, Jacob A. Schwartzman, Joshua A. Urrutia, Eva S. Rodansky, Anbarasu Kumaraswamy, Xiangnan Guan, David Sampson, Daniel J. Coleman, Chelsea Jenkins, Katherine Welker Leng, William K. Storck, Duanchen Sun, Dae-Hwan Kim
Supplementary Table S2 S4 S6 S7 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16078ca74f4249c0affafe9aadcfadc3
https://doi.org/10.1158/1078-0432.22481645.v1
https://doi.org/10.1158/1078-0432.22481645.v1
Autor:
Joshi J. Alumkal, Zheng Xia, Joel A. Yates, Eric Campeau, Sanjay Lakhotia, Sarah Attwell, Emily M. Gesner, Arvind Rao, Armand Bankhead, Daniel E. Spratt, Eric J. Small, Felix Y. Feng, Wassim Abida, Rahul Aggarwal, Jonathan Z. Sexton, Samuel K. Handelman, Eva Corey, Peter S. Nelson, Ilsa M. Coleman, Jared M. Lucas, Colm Morrissey, Mark P. Labrecque, Himisha Beltran, Chao Zhang, Jacob A. Schwartzman, Joshua A. Urrutia, Eva S. Rodansky, Anbarasu Kumaraswamy, Xiangnan Guan, David Sampson, Daniel J. Coleman, Chelsea Jenkins, Katherine Welker Leng, William K. Storck, Duanchen Sun, Dae-Hwan Kim
Supplementary Table S3 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fac14709a2fec2f4b783b7663c42d28
https://doi.org/10.1158/1078-0432.22481642.v1
https://doi.org/10.1158/1078-0432.22481642.v1
Autor:
John K. Lee, Peter S. Nelson, Colm Morrissey, Michael T. Schweizer, Michael C. Haffner, Lawrence D. True, Eva Corey, Rui M. Gil da Costa, Ilsa Coleman, Navonil De Sarkar, James E. Hopkins, Ailin Zhang, Mark P. Labrecque, Lisa Ang, Thomas M. Cardillo, Diana C. DeLucia
Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fa05ba977f498d125649c70a580fe6
https://doi.org/10.1158/1078-0432.22479233
https://doi.org/10.1158/1078-0432.22479233
Autor:
Joshi J. Alumkal, Zheng Xia, Joel A. Yates, Eric Campeau, Sanjay Lakhotia, Sarah Attwell, Emily M. Gesner, Arvind Rao, Armand Bankhead, Daniel E. Spratt, Eric J. Small, Felix Y. Feng, Wassim Abida, Rahul Aggarwal, Jonathan Z. Sexton, Samuel K. Handelman, Eva Corey, Peter S. Nelson, Ilsa M. Coleman, Jared M. Lucas, Colm Morrissey, Mark P. Labrecque, Himisha Beltran, Chao Zhang, Jacob A. Schwartzman, Joshua A. Urrutia, Eva S. Rodansky, Anbarasu Kumaraswamy, Xiangnan Guan, David Sampson, Daniel J. Coleman, Chelsea Jenkins, Katherine Welker Leng, William K. Storck, Duanchen Sun, Dae-Hwan Kim
Purpose:Lineage plasticity in prostate cancer—most commonly exemplified by loss of androgen receptor (AR) signaling and a switch from a luminal to alternate differentiation program—is now recognized as a treatment resistance mechanism. Lineage pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::048c54987968c92a1c3c681235482238
https://doi.org/10.1158/1078-0432.c.6530747.v1
https://doi.org/10.1158/1078-0432.c.6530747.v1